TPIAT
ProcedureThe entire pancreas is removed to treat the pain of chronic pancreatitis, and the islets are infused back into the patient to reduce diabetes risk after surgery.
NCT Number: NCT03260387
Multi-center, prospective, observational cohort study of patients undergoing total pancreatectomy with islet autotransplantation (TPIAT)
This study is active but is not currently recruiting participants.
All sexes
Observational
University of California, San Francisco, San Francisco, California, United States
Patients who are undergoing TPIAT at one of the participating center are invited to participate in this observational study, with 450 participants anticipated. The aims of the study are:
Aim 1: To determine (1a) whether patient and disease characteristics are associated with favorable pain and health-related quality-of-life outcomes (HRQOL) after TPIAT; (1b) the optimal timing of the TPIAT intervention to resolve pain and improve HRQOL; and (1c) in a subset of patients, the impact of central sensitization on pain resolution.
Aim 2: To determine (2a) whether patient and disease characteristics are associated with favorable glycemic outcomes from the IAT procedure; and (2b) the optimal timing of TPIAT to obtain post-surgical insulin independence.
Aim 3: To determine the cost-effectiveness of TPIAT.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The entire pancreas is removed to treat the pain of chronic pancreatitis, and the islets are infused back into the patient to reduce diabetes risk after surgery.
Time frame: Mos 6, Years 1, 2, 3, 4 after surgery
Visual Analog Pain Scale
Time frame: Mos 6, Years 1, 2, 3, 4 after surgery
Physical Component Summary Score from SF-12
Time frame: Mos 6, Years 1, 2, 3, 4 after surgery
Mental Component Summary Score from SF-12
Time frame: Mos 6, Years 1, 2, 3, 4 after surgery
Proportion of patients insulin independent
Time frame: Mos 6, Years 1, 2, 3, 4 after surgery
proportion off opioid analgesics
Time frame: Mos 6, Years 1, 2, 3, 4 after surgery
Morphine Equivalents (avg daily ME)
Time frame: Mos 6, Years 1, 2, 3, 4 after surgery
HbA1c level
Time frame: Mos 6, Years 1, 2, 3, 4 after surgery
Insulin Dose (U/day)
Time frame: Mos 6, Years 1, 2, 3, 4 after surgery
Proportion with Islet Graft Function (C-peptide + or Off Insulin)
Time frame: Mos 6, Years 1, 2, 3, 4 after surgery
Proportion of patients with Severe Hypoglycemia
Time frame: Mos 6, Years 1, 2, 3, 4 after surgery
Pain interference Score (PROMIS scale)
University of Minnesota
Other
Advancing Treatment for Pancreatitis: A Prospective Observational Study of TPIAT (POST)
Acronym: POST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04760847
Acute Recurrent Pancreatitis, Behavior
Tampa, Florida, United States
View Trial DetailsNCT00676702
Brain Damage, Chronic, Brain Diseases
View Trial DetailsNCT07202559
Chronic Disease, Digestive System Diseases
Baotou, China
View Trial DetailsNCT06729996
Chronic Disease, Diabetes Mellitus
Rochester, Minnesota, United States
View Trial Details